Mohamed Eid

Mohamed Eid, MD, MSc, MHA, serves as the Head of Clinical Development & Medical Affairs at Boehringer Ingelheim since March 2019. With extensive experience in the pharmaceutical industry, Mohamed held multiple leadership roles at Novo Nordisk from 2003 to 2019, including Corporate Vice President and Chief Medical Officer. Earlier career highlights include positions at Takeda as Medical & Scientific Affairs Program Leader and at Bristol-Myers Squibb as Medical Science Manager. Mohamed's academic achievements include advanced degrees in Healthcare Administration and Clinical Research from the University of Minnesota, as well as executive education from the University of Oxford and Harvard Business School.